logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11084828 B1

PDFFull Text
Date of Patent:
Aug. 10, 2021

Filed:

Jun. 11, 2019

Use of the fl118 core chemical structure platform to generate fl118 derivatives for treatment of human disease

Applicant:

Canget Biotekpharma, Llc, Buffalo, NY (US);

Inventors:

Fengzhi Li, Buffalo, NY (US);

Xiang Ling, Buffalo, NY (US);

Assignee:

Ganget BioTekpharma, LLC, Buffalo, NY (US);

Attorney:

McAndrews Held & Malloy, Ltd.

Primary Examiner:

Samira J Jean-Louis

Int. Cl.
CPC ...
C07D 491/22 (2006.01); A61K 45/06 (2006.01); A61K 31/4745 (2006.01); A61P 35/00 (2006.01); A61K 9/19 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/20 (2006.01); A61K 47/34 (2017.01); A61K 47/38 (2006.01); A61K 47/40 (2006.01);
U.S. Cl.
CPC ...
C07D 491/22 (2013.01); A61K 9/19 (2013.01); A61K 31/4745 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/20 (2013.01); A61K 47/34 (2013.01); A61K 47/38 (2013.01); A61K 47/40 (2013.01); A61P 35/00 (2018.01);
Abstract

Described herein, are FL118 core structure platform compounds, matter of compositions, formulation, methods and uses for treating cancer or other human diseases. Chemical modifications of the FL118 structure are employed alone or in combination with other anti-cancer agents to preclude or reverse refractory cancer phenotypes and for unique personalized cancer treatment (personalized medicine or as Obama called precision medicine) through application of a series of structural relevant individual FL118 platform-derived analogues.

Find Patent Forward Citations

Li, Fengzhi. (2021). Use of the fl118 core chemical structure platform to generate fl118 derivatives for treatment of human disease (U.S. Patent No. 11084828). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11084828

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…